GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioCryst Pharmaceuticals Inc (FRA:BO1) » Definitions » Equity Investments

BioCryst Pharmaceuticals (FRA:BO1) Equity Investments


View and export this data going back to 1994. Start your Free Trial

What is BioCryst Pharmaceuticals Equity Investments?

Equity Investments only applies to insurance companies.


BioCryst Pharmaceuticals (FRA:BO1) Business Description

Traded in Other Exchanges
Address
4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.